ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/26 | 3,305 | 3,325 | 3,270 | 3,305 | -15 | -0.5% | 28,700 |
| 2024/04/25 | 3,340 | 3,360 | 3,310 | 3,320 | -15 | -0.4% | 26,900 |
| 2024/04/24 | 3,320 | 3,335 | 3,300 | 3,335 | +30 | +0.9% | 22,900 |
| 2024/04/23 | 3,310 | 3,320 | 3,290 | 3,305 | -5 | -0.2% | 16,900 |
| 2024/04/22 | 3,255 | 3,310 | 3,255 | 3,310 | +70 | +2.2% | 15,900 |
| 2024/04/19 | 3,275 | 3,275 | 3,200 | 3,240 | -30 | -0.9% | 43,900 |
| 2024/04/18 | 3,275 | 3,300 | 3,270 | 3,270 | -5 | -0.2% | 20,600 |
| 2024/04/17 | 3,330 | 3,330 | 3,275 | 3,275 | -45 | -1.4% | 38,100 |
| 2024/04/16 | 3,365 | 3,365 | 3,320 | 3,320 | -50 | -1.5% | 29,200 |
| 2024/04/15 | 3,365 | 3,380 | 3,355 | 3,370 | -15 | -0.4% | 18,200 |
| 2024/04/12 | 3,385 | 3,400 | 3,360 | 3,385 | ±0 | ±0% | 19,000 |
| 2024/04/11 | 3,400 | 3,410 | 3,380 | 3,385 | -35 | -1% | 23,300 |
| 2024/04/10 | 3,405 | 3,445 | 3,390 | 3,420 | +20 | +0.6% | 49,800 |
| 2024/04/09 | 3,380 | 3,400 | 3,360 | 3,400 | +25 | +0.7% | 45,800 |
| 2024/04/08 | 3,360 | 3,390 | 3,340 | 3,375 | +25 | +0.7% | 44,400 |
| 2024/04/05 | 3,325 | 3,350 | 3,305 | 3,350 | +20 | +0.6% | 28,200 |
| 2024/04/04 | 3,340 | 3,350 | 3,310 | 3,330 | -10 | -0.3% | 51,100 |
| 2024/04/03 | 3,310 | 3,370 | 3,305 | 3,340 | +45 | +1.4% | 47,100 |
| 2024/04/02 | 3,345 | 3,345 | 3,290 | 3,295 | -50 | -1.5% | 44,700 |
| 2024/04/01 | 3,365 | 3,370 | 3,325 | 3,345 | -20 | -0.6% | 60,100 |
| 2024/03/29 | 3,275 | 3,365 | 3,270 | 3,365 | +110 | +3.4% | 78,600 |
| 2024/03/28 | 3,235 | 3,280 | 3,230 | 3,255 | +20 | +0.6% | 28,600 |
| 2024/03/27 | 3,235 | 3,305 | 3,235 | 3,235 | +15 | +0.5% | 75,800 |
| 2024/03/26 | 3,235 | 3,235 | 3,195 | 3,220 | -10 | -0.3% | 57,700 |
| 2024/03/25 | 3,250 | 3,270 | 3,230 | 3,230 | -20 | -0.6% | 37,100 |
| 2024/03/22 | 3,245 | 3,270 | 3,205 | 3,250 | +20 | +0.6% | 74,300 |
| 2024/03/21 | 3,270 | 3,270 | 3,225 | 3,230 | -45 | -1.4% | 83,500 |
| 2024/03/19 | 3,275 | 3,275 | 3,245 | 3,275 | ±0 | ±0% | 30,700 |
| 2024/03/18 | 3,270 | 3,280 | 3,255 | 3,275 | +15 | +0.5% | 35,200 |
| 2024/03/15 | 3,285 | 3,290 | 3,225 | 3,260 | -30 | -0.9% | 82,900 |
| 2024/03/14 | 3,285 | 3,310 | 3,260 | 3,290 | +30 | +0.9% | 37,700 |
| 2024/03/13 | 3,325 | 3,330 | 3,245 | 3,260 | -60 | -1.8% | 40,400 |
| 2024/03/12 | 3,265 | 3,320 | 3,250 | 3,320 | +50 | +1.5% | 43,700 |
| 2024/03/11 | 3,295 | 3,300 | 3,250 | 3,270 | -25 | -0.8% | 31,000 |
| 2024/03/08 | 3,245 | 3,325 | 3,245 | 3,295 | +45 | +1.4% | 55,700 |
| 2024/03/07 | 3,285 | 3,300 | 3,250 | 3,250 | -30 | -0.9% | 40,000 |
| 2024/03/06 | 3,280 | 3,305 | 3,275 | 3,280 | -10 | -0.3% | 40,400 |
| 2024/03/05 | 3,345 | 3,365 | 3,280 | 3,290 | -55 | -1.6% | 51,700 |
| 2024/03/04 | 3,340 | 3,375 | 3,325 | 3,345 | +5 | +0.1% | 46,300 |
| 2024/03/01 | 3,355 | 3,385 | 3,330 | 3,340 | +10 | +0.3% | 47,500 |
| 2024/02/29 | 3,300 | 3,345 | 3,255 | 3,330 | +25 | +0.8% | 52,400 |
| 2024/02/28 | 3,255 | 3,330 | 3,255 | 3,305 | +65 | +2% | 64,700 |
| 2024/02/27 | 3,320 | 3,320 | 3,240 | 3,240 | -105 | -3.1% | 142,100 |
| 2024/02/26 | 3,355 | 3,375 | 3,325 | 3,345 | ±0 | ±0% | 48,600 |
| 2024/02/22 | 3,375 | 3,385 | 3,335 | 3,345 | -30 | -0.9% | 58,000 |
| 2024/02/21 | 3,400 | 3,405 | 3,360 | 3,375 | -30 | -0.9% | 37,100 |
| 2024/02/20 | 3,450 | 3,470 | 3,385 | 3,405 | -40 | -1.2% | 58,100 |
| 2024/02/19 | 3,380 | 3,450 | 3,380 | 3,445 | +70 | +2.1% | 46,100 |
| 2024/02/16 | 3,370 | 3,420 | 3,340 | 3,375 | +30 | +0.9% | 80,400 |
| 2024/02/15 | 3,400 | 3,430 | 3,315 | 3,345 | -105 | -3% | 163,000 |
1～
50
件表示中 / 2042件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 330,500円 | -5.1% | -21.2% | 4.84% | 10.44倍 | 2.01倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ダイト | 251,800円 | +5.3% | -7.1% | 2.38% | 11.94倍 | 0.76倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| 富士製薬 | 155,200円 | +19.7% | +23.1% | 2.74% | 6.10倍 | 0.92倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| セルソース | 152,200円 | +19.0% | -13.1% | 0.33% | 41.93倍 | 4.90倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| サンバイオ | 41,900円 | - | - | 0.00% | - | 11.12倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
